within Pharmacolibrary.Drugs.ATC.M;

model M02AA31
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.95,
    Cl             = 9.316666666666666e-05,
    adminDuration  = 600,
    adminMass      = 60 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00977,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.010166666666666666,
    Tlag           = 9.6,            
    Vdp             = 0.007719999999999999,
    k12             = 11.2,
    k21             = 11.2
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M02AA31</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Loxoprofen is a non-steroidal anti-inflammatory drug (NSAID) used for the relief of pain and inflammation in conditions such as musculoskeletal disorders, osteoarthritis, and postoperative pain. It is primarily approved in Japan and some other Asian countries but is not approved by the FDA in the United States.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult Japanese volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Adachi, K, et al., &amp; Yamazaki, H (2021). Pharmacokinetics of loxoprofen in a self-administered overdose in a Japanese patient admitted to hospital. <i>Journal of pharmaceutical health care and sciences</i> 7(1) 33–None. DOI:<a href=\"https://doi.org/10.1186/s40780-021-00216-9\">10.1186/s40780-021-00216-9</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34488903/\">https://pubmed.ncbi.nlm.nih.gov/34488903</a></p></li><li><p>Koo, TS, et al., &amp; Chung, SJ (2005). Comparison of pharmacokinetics of loxoprofen and its active metabolites after an intravenous, intramuscular, and oral administration of loxoprofen in rats: evidence for extrahepatic metabolism. <i>Journal of pharmaceutical sciences</i> 94(10) 2187–2197. DOI:<a href=\"https://doi.org/10.1002/jps.20451\">10.1002/jps.20451</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16136574/\">https://pubmed.ncbi.nlm.nih.gov/16136574</a></p></li><li><p>Sawamura, R, et al., &amp; Izumi, T (2015). Pharmacokinetics of loxoprofen and its active metabolite after dermal application of loxoprofen gel to rats. <i>Die Pharmazie</i> 70(2) 74–80. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25997245/\">https://pubmed.ncbi.nlm.nih.gov/25997245</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M02AA31;
